Načítá se...

High cumulative doxorubicin dose for advanced soft tissue sarcoma

BACKGROUND: The recommended cumulative doxorubicin dose in soft tissue sarcoma (STS) treatment was based on cardiotoxicity data from retrospective studies of breast cancer patients. However, the treatment and prognosis of STS and breast cancer are quite different, and reference to breast cancer data...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Tian, Zhichao, Yang, Yang, Yang, Yonghao, Zhang, Fan, Li, Po, Wang, Jiaqiang, Yang, Jinpo, Zhang, Peng, Yao, Weitao, Wang, Xin
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7684756/
https://ncbi.nlm.nih.gov/pubmed/33228579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07663-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!